US Patent Issued to ACTINIUM PHARMACEUTICALS on Sept. 1 for "HER3 radioimmunotherapy for the treatment of solid cancers" (New Jersey, New York Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,915, issued on Sept. 1, was assigned to ACTINIUM PHARMACEUTICALS INC. (New York).

"HER3 radioimmunotherapy for the treatment of solid cancers" was invented by Dale L Ludwig (Rockaway, N.J.), Eileen Geoghegan (Mamaroneck, N.Y.), Sandesh Seth (New York) and Paul Diamond (Fort Lee, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are compositions and methods for treating a solid cancer such as a HER3-positive tumor in a subject by administering an effective amount of a HER3-targeting agent labeled with a radionuclide such as 225Ac, 177Lu, 131I, 90Y, 213Bi, 211At, 213Bi, 227Th, or 212Pb, alone or in combination with other therapeutic agents ...